• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareHealthcare Equipment & SuppliesEOFlow
    Picture of EOFlow logo

    294090 — EOFlow Share News

    KR₩1,4900.000.00%
    kr flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro Cap
    • Market Cap
    • Enterprise Value
    • Revenue
      KR₩4bn
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • 294090 Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    294090 Dividends
    • US court overturns Insulet's $59 million insulin-pump trade secret verdict against EOFlow (updated)

      28/05/2026 17:08
    • Corrected: US court overturns Insulet's $59 mln insulin-pump trade secret verdict against EOFlow

      28/05/2026 16:43
    • Corrected: UPDATE 1-US court overturns Insulet's $59 mln insulin-pump trade secret verdict against EOFlow

      28/05/2026 15:33
    • US court overturns Insulet's $452 mln insulin-pump trade secret verdict against EOFlow

      28/05/2026 15:12
    • Insulet wins $452 mln US verdict against EOFlow in insulin pump secrets case

      05/12/2024 15:59
    • Brief: Eoflow To Conduct Capital Increase Of 82 Billion Won

      21/08/2024 09:05
    • Insulet shares rebound after earnings sell-off

      14/05/2024 18:34
    • Medtronic falls as annual profit forecast misses expectations

      25/05/2023 15:07
    • Brief: Medtronic To Acquire Wearable Insulin Patch Maker Eoflow

      25/05/2023 13:29
    • Medtronic forecasts annual profit below estimates (updated)

      25/05/2023 12:00
    • Brief: EOFlow Co Wins 778 Million Won Order

      25/07/2022 06:21
    • Brief: Eoflow And Zihipp Announce Joint Venture For Development Of Innovative Solutions For Treatment Of Obesity & Nash

      28/12/2021 14:10

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.